February 15, 2022
-
February 15, 2022
Statewide Health Care Facility Transformation Program III RFA Deadline Extended to Feb. 22nd Providers can reopen their applications to rework and resubmit.
- Read More
-
February 15, 2022
SFY 2022-23 Budget Advocacy Letters Now Available! LeadingAge NY encourages members to send letters to their legislators and the Governor TODAY, as well as share the letters with colleagues and board members to expand our advocacy reach.
- Read More
-
February 15, 2022
Feb. 15th COVID-19 Update Latest updates for providers of LTPAC and senior services.
- Read More
-
February 15, 2022
DOL Announces Continued Designation of COVID-19 as Airborne Infectious Disease Under HERO Act The ongoing implementation of workplace safety plans is required for those who must follow the HERO Act.
- Read More
-
February 15, 2022
Governor Ends Mask Mandate for Certain Businesses Implications for various LeadingAge NY providers regarding mask mandate changes.
- Read More
-
February 15, 2022
LeadingAge NY Offers Comments on Personal and Compassionate Caregiving Visitor Regulations LeadingAge NY provides comments on regulations impacting nursing homes and ACFs.
- Read More
-
February 15, 2022
DOH/IPRO Hold Webinar on Booster Vaccine in Nursing Homes and ACFs LeadingAge NY provides highlights of a free webinar held by DOH and IPRO on the COVID-19 booster and how it is affecting the nursing home and ACF settings.
- Read More
-
February 15, 2022
Provider Relief Reporting Webinar HRSA to provide free Nursing Home Infection Control webinar on Feb. 17th.
- Read More
-
February 15, 2022
CMS Provides Updates on National Guard PBJ Reporting and Kronos Issue LeadingAge National received updates late last week from CMS on two outstanding issues.
- Read More
-
February 15, 2022
DOH Allocates Oral Anti-Viral Medication to LTC Pharmacies for Nursing Home Use Last week, DOH allocated 1,800 treatment courses of Molnupiravir, an oral anti-viral medication, to long term care pharmacies for nursing home use.
- Read More
-
- view more